Register to receive a free European Minimally Invasive Spinal Implant Market report synopsis and brochure
According to a recent report by iData Research, Zimmer is one of the leading competitors in the European minimally invasive spinal implant market. The company competed in both segments and markets its products in this area under its own spine division. Products offered by the spine division provide comprehensive solutions for patients suffering through back or neck pain caused by degenerative condition, deformities or traumatic injury of the spine.
On June 24th, 2015, the acquisition of Biomet by Zimmer Holdings was completed. The acquisition transaction was valued at approximately $14 billion, making it one of the largest acquisitions in the orthopedic market space. Although Biomet was not an active player in the minimally invasive spinal implant market, the merger will provide access to Biomet accounts that could benefit from minimally invasive products and were not already using Zimmer. The merger not only strengthens the combined entity’s foothold in other orthopedic markets, but also enables Zimmer’s spinal implant product line to experience increased market share.
“The coming together of Zimmer and Biomet is a momentous achievement. We are excited to move forward as one company and to pursue new opportunities that benefit patients, healthcare professionals and employees around the globe,” said David Dvorak, President and CEO of Zimmer Biomet. “Over the past several months, our integration planning teams have been working to ensure that we capture the best of both companies and create a seamless and efficient transition. I look forward to continuing to work closely with our employees for the benefit of all of our stakeholders.”
On July 3rd, 2015, Italian medical device company Lima Corporate, completed the acquisition of several Zimmer Biomet product lines. The products will now be fully integrated into the Lima portfolio and business units. According to the agreement, Lima will also take over the supply chain.
“The completion of this acquisition gives Lima a big step up in the knee and extremities markets. The Zimmer® ZUK and the Biomet® Vanguard™ Complete Knee System will open doors for the rapid expansion in the knee market. We are already a market leader in total shoulder arthroplasty and the Biomet® Discovery™ Elbow System will allow us to expand our position,” said Luigi Ferrari, CEO of Lima Corporate.
Founded in 1927 and headquartered in Warsaw, Indiana, USA, Zimmer Biomet is a global leader in musculoskeletal healthcare. We design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products.
About Lima Corporate
Lima Corporate is a global medical device company providing reconstructive orthopaedic solutions to surgeons who face the challenges of improving the quality of life of their patients. Based in Italy, Lima Corporate is committed to the development of innovative products and procedures to enable surgeons to select ideal solution for every individual patient. Lima Corporate’s product range includes large joint revision and primary implants and complete extremities solutions including fixation.
Explore our careers page for our current available job opportunities. This is your chance to join a fun and dynamic team in the medical market research industry. Send your resume to [email protected] with the job title in the subject line, and feel free to tell us a little about yourself. We look forward to hearing from you.